Cowen's best ideas for biotech is Argenx (ARGX). Yaron Werber discusses ARGX as its lead candidate "vyvgart" has been a best-in-class profile with the first mover advantage in this space. He notes that Cowen has an outperform rating with a $441 price target on ARGX. He also talks about some of Cowen's other biotech picks which include Relay Therapeutics (RPLAY) and PMV Pharmaceutical (PMVP). He then goes over the outlook for biotech in 2023. Tune in to find out more about the stock market today.
The Watch List
09 Dec 2022
SHARE
Morning Trade Live
15 Sep 2023
Market On Close
24 Oct 2023
Morning Trade Live
06 Dec 2023
Trading 360
09 Nov 2023
The Watch List
21 Sep 2023
Market On Close
09 Nov 2023